RAI2 and breast cancer: Further investigations pointed out that RAI2 promoted the expression of various cellular differentiation genes by interacting with the transcription factor carboxyl-terminal binding protein 2 (CtBP2), which ultimately inhibited the early hematogenous metastasis of human breast cancer cells to bone marrow.